GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PELL Bio-Med Technology Co Ltd (TPE:6949) » Definitions » PensionAndRetirementBenefit

PELL Bio-Med Technology Co (TPE:6949) PensionAndRetirementBenefit : NT$0.00 Mil (As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is PELL Bio-Med Technology Co PensionAndRetirementBenefit?

PELL Bio-Med Technology Co's PensionAndRetirementBenefit for the quarter that ended in Mar. 2025 was NT$0.00 Mil.


PELL Bio-Med Technology Co PensionAndRetirementBenefit Historical Data

The historical data trend for PELL Bio-Med Technology Co's PensionAndRetirementBenefit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PELL Bio-Med Technology Co PensionAndRetirementBenefit Chart

PELL Bio-Med Technology Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24
PensionAndRetirementBenefit
- - - -

PELL Bio-Med Technology Co Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
PensionAndRetirementBenefit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

PELL Bio-Med Technology Co PensionAndRetirementBenefit Calculation

PensionAndRetirementBenefit is the carrying amount as of the balance sheet date of the portion of the obligations recognized for the various benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement.


PELL Bio-Med Technology Co Business Description

Traded in Other Exchanges
N/A
Address
No. 87, Xinhu 2nd Road, 4th Floor, Neihu District, Taipei, TWN
PELL Bio-Med Technology Co Ltd is a company engaged in the research and development and application of autologous T Cell Therapy (Adoptive T Cell Therapy), CAR-T (Chimeric Antigen Receptor T cell), and Gene-Modified Adipose-Derived Stem Cell (Gene-Modified Adipose-Derived Stem Cell).

PELL Bio-Med Technology Co Headlines

No Headlines